miércoles, 2 de abril de 2025

Experimental women's cancer drug boosts survival rates in notable study Patients with treatment-resistant ovarian cancer saw 30% less risk of disease progression Angelica Stabile By Angelica Stabile Fox News Published April 1, 2025 3:23pm EDT

Experimental women's cancer drug boosts survival rates in notable study Patients with treatment-resistant ovarian cancer saw 30% less risk of disease progression Angelica Stabile By Angelica Stabile Fox News Published April 1, 2025 3:23pm EDT https://www.foxnews.com/health/experimental-womens-cancer-drug-boosts-survival-rates-notable-study

No hay comentarios:

Publicar un comentario